- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Abbott Today
By the People, for the People
Rathbones Group PLC Increases Stake in Abbott Laboratories
Investment firm boosts ownership in healthcare product maker to over $400 million
Published on Mar. 8, 2026
Got story updates? Submit your updates here. ›
Rathbones Group PLC, a UK-based investment management firm, has increased its stake in Abbott Laboratories (NYSE:ABT) by 4.6% during the third quarter. The firm now owns 3,008,738 shares of the healthcare product maker's stock, valued at approximately $402.99 million as of its most recent SEC filing.
Why it matters
Abbott Laboratories is a major global healthcare company that develops and manufactures a wide range of medical products and services. Rathbones Group's increased investment in Abbott suggests the firm sees long-term growth potential in the company's business and product portfolio.
The details
Rathbones Group PLC lifted its stake in Abbott Laboratories by adding 132,256 shares during the third quarter. This increased the firm's total holding to 3,008,738 shares, which account for approximately 1.6% of Rathbones Group's overall investment portfolio. Abbott Laboratories is now the 12th largest position held by Rathbones Group.
- Rathbones Group PLC increased its stake in Abbott Laboratories during the third quarter of 2025.
The players
Rathbones Group PLC
A UK-based investment management firm that oversees over $50 billion in client assets.
Abbott Laboratories
A global healthcare company that develops and manufactures a broad portfolio of medical products and services.
The takeaway
Rathbones Group's increased investment in Abbott Laboratories reflects the firm's confidence in the healthcare company's long-term growth prospects. As a major player in the global medical products industry, Abbott's performance is closely watched by investors seeking exposure to the healthcare sector.
